AURA
AstraZeneca
AstraZeneca
Eli Lilly and Company
Cancer Research UK
Turning Point Therapeutics, Inc.
Eisai Inc.
NeoImmuneTech
Revolution Medicines, Inc.
Sichuan Enray Pharmaceutical Sciences Company
A2 Biotherapeutics Inc.
Essen Biotech
Essen Biotech
Revolution Medicines, Inc.
DualityBio Inc.
Grey Wolf Therapeutics
M.D. Anderson Cancer Center
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Eli Lilly and Company
Inhibrx Biosciences, Inc
Tyligand Pharmaceuticals (Suzhou) Limited
GV20 Therapeutics
Shasqi, Inc.
Krystal Biotech, Inc.
Daiichi Sankyo
Proton Collaborative Group
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
NuCana plc
PharmaMar
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Bristol-Myers Squibb
Cancer Research UK
Hoffmann-La Roche
Numab Therapeutics AG
Verastem, Inc.
Novartis
A2 Biotherapeutics Inc.
Xynomic Pharmaceuticals, Inc.
Intensity Therapeutics, Inc.
GV20 Therapeutics
Immunophotonics, Inc.
OncoResponse, Inc.
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
GlaxoSmithKline